DR. MAXWELL & PARTNERS
RIVERSIDE MEDICAL, RIVERSIDE MEDICAL, CASTLEROCK ROAD, COLERAINE
AF006NI
The percentage of patients with atrial fibrillation in whom stroke risk has been assessed using the CHA2DS2-VASc score risk stratification scoring system in the preceding 3 years (excluding those patients with aCHADS2 or CHA2DS2-VASc score of 2 or more)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| AF 5 | 2013 | 64 | 64 | 100.0% | |
| AF002NI | 2014 | 87 | 87 | 100.0% | |
| AF002 | 2015 | 107 | 107 | 100.0% | |
| AF006NI | 2016 | 101 | 106 | 95.3% | |
| AF006NI | 2017 | 104 | 109 | 95.4% | |
| AF006NI | 2018 | 111 | 115 | 96.5% | |
| AF006NI | 2019 | 113 | 122 | 92.6% | |
| AF006NI | 2020 | 115 | 125 | 92.0% | |
| AF006NI | 2021 | 107 | 124 | 86.3% |
